Voloridge Investment Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Voloridge Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $4.75 Million - $4.99 Million	-32,744 Reduced 25.2%	97,175 $14.7 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $4.1 Million - $7.21 Million	49,367 Added 61.29%	129,919 $18.9 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $4.56 Million - $5.92 Million	-41,394 Reduced 33.94%	80,552 $9.55 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $5.98 Million - $8.9 Million	-59,958 Reduced 32.96%	121,946 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $16.8 Million - $23.6 Million	170,177 Added 1451.16%	181,904 $25.3 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $868,493 - $1.39 Million	-13,203 Reduced 52.96%	11,727 $1.14 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $51,576 - $73,858	-805 Reduced 3.13%	24,930 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $2.68 Million - $4.05 Million	-41,261 Reduced 61.59%	25,735 $2.21 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $1.21 Million - $1.59 Million	-20,457 Reduced 23.39%	66,996 $4.36 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $2.29 Million - $5.87 Million	79,053 Added 941.11%	87,453 $6.39 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $231,084 - $481,236	8,400 New	8,400 $286,000
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $515,837 - $868,717	-12,964 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $447,517 - $690,851	12,964 New	12,964 $667,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.